Identification of potential biomarkers for giant cell tumor of bone using comparative proteomics analysis.
about
Translational research in diagnosis and management of soft tissue tumoursAnti-cancer effect of thiacremonone through down regulation of peroxiredoxin 6Loss of presenilin 2 is associated with increased iPLA2 activity and lung tumor development.Aged monkey brains reveal the role of ubiquitin-conjugating enzyme UBE2N in the synaptosomal accumulation of mutant huntingtin.Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab.Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor.Tartrate-Resistant Acid Phosphatase 5b is a Useful Serum Marker for Diagnosis and Recurrence Detection of Giant Cell Tumor of Bone.Tissue and serum IGFBP7 protein as biomarker in high-grade soft tissue sarcomaBiomarkers for Bone Tumours: Discovery from Genomics and Proteomics Studies and Their Challenges.Retrospective analysis of patients with rare-site and metastatic giant cell tumor.Orthopaedic research in italy: state of the art.Proteomics in investigation of cancer metastasis: functional and clinical consequences and methodological challenges.Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma.UBE2Q1, as a Down Regulated Gene in Pediatric Acute Lymphoblastic LeukemiaPrognosis of local recurrence in giant cell tumour of bone: what can we do?Presenilin Mutation Suppresses Lung Tumorigenesis via Inhibition of Peroxiredoxin 6 Activity and Expression.p53 mutations may be involved in malignant transformation of giant cell tumor of bone through interaction with GPX1.Prognostic role of nuclear factor/IB and bone remodeling proteins in metastatic giant cell tumor of bone: A retrospective study.
P2860
Q26748651-1C1D5184-D3EC-44B5-A1B1-55E1299964CFQ28540752-B347A0AC-C4EC-4F5B-94A2-002ED903FF91Q34876944-20A62D08-1F03-4DE8-919B-42D0CAD60AB2Q35063149-0D0FD5E1-0D62-4301-AA9A-3F8B356AB259Q35919620-13B42B27-7B1B-4473-A2E3-A4FDECDEA7E9Q35988028-5C45B260-35B5-449B-8EF4-C593E5EF4FF0Q36212068-9EA05139-3D80-44B5-8A18-ED715E38A5B4Q36420180-32F2A01C-F2B3-4A94-86FA-F5885AF3F6B8Q36758011-BF9C68DD-4BA0-4022-9A0C-C2CC950AFB26Q37309465-AB9B6719-BF64-4189-B513-60F9F30C3D57Q37888852-F37FA85C-2853-4E92-A775-C026B35E6EF2Q38165894-C69480AA-C25B-4AD9-BE6D-5F23CF7448EBQ38484441-C25E2A20-B46C-44E6-8462-300C15E3A0F8Q39158191-BEF10F73-A48B-4312-8732-68CA0FF0D70FQ39167478-B80D3918-3B90-46FB-938A-8014B3E27C4CQ47122996-BC30FB5F-88FE-4E84-8083-79338A2395AAQ50924369-6E19A2E9-E944-4FAF-BFD1-4F6F091E40E9Q53586132-AD187034-ED34-45A4-AFCB-71690C7CD070
P2860
Identification of potential biomarkers for giant cell tumor of bone using comparative proteomics analysis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Identification of potential bi ...... mparative proteomics analysis.
@ast
Identification of potential bi ...... mparative proteomics analysis.
@en
Identification of potential bi ...... mparative proteomics analysis.
@nl
type
label
Identification of potential bi ...... mparative proteomics analysis.
@ast
Identification of potential bi ...... mparative proteomics analysis.
@en
Identification of potential bi ...... mparative proteomics analysis.
@nl
prefLabel
Identification of potential bi ...... mparative proteomics analysis.
@ast
Identification of potential bi ...... mparative proteomics analysis.
@en
Identification of potential bi ...... mparative proteomics analysis.
@nl
P2093
P2860
P50
P1476
Identification of potential bi ...... omparative proteomics analysis
@en
P2093
Amalia Conti
Gemma Caballero Rodriguez
Licciana Zanella
Maria Serena Benassi
Rosa Maria Dégano Blazquez
Tibor Krènacs
Victoria Barbado
P2860
P356
10.1016/J.AJPATH.2010.11.035
P407
P577
2010-12-23T00:00:00Z